TBI - TrueBlue, Inc. Stock Analysis | Stock Taper
Logo
TrueBlue, Inc.

TBI

TrueBlue, Inc. NYSE
$4.12 -2.60% (-0.11)

Market Cap $126.64 M
52w High $7.78
52w Low $3.44
P/E -4.25
Volume 317.61K
Outstanding Shares 29.94M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $418.18M $95.45M $-31.54M -7.54% $-1.06 $-4.38M
Q3-2025 $431.27M $98.04M $-1.92M -0.44% $-0.06 $7.2M
Q2-2025 $396.3M $96.5M $-160K -0.04% $-0.01 $4.76M
Q1-2025 $370.25M $100.47M $-14.35M -3.88% $-0.48 $-7.31M
Q4-2024 $385.95M $112.95M $-11.71M -3.03% $-0.4 $-3.46M

What's going well?

Interest and other expenses are down, so the company isn't being dragged down by debt or unusual costs. The share count is stable, so existing shareholders aren't being diluted.

What's concerning?

Sales are falling, gross profit is down, and losses have widened sharply. The core business is unprofitable, and margins are getting squeezed.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $24.51M $638.67M $364.11M $274.56M
Q3-2025 $19.89M $690.53M $386.19M $304.34M
Q2-2025 $21.9M $672.78M $367.59M $305.19M
Q1-2025 $23.06M $692.47M $390.25M $302.22M
Q4-2024 $22.54M $675.38M $360.02M $315.36M

What's financially strong about this company?

TBI has strong liquidity with over twice as many current assets as current liabilities, and a large portion of assets are in cash and receivables. The company is efficient with no inventory risk and a history of profitability.

What are the financial risks or weaknesses?

Debt jumped sharply this quarter, and equity shrank, which could be a warning sign if the trend continues. Cash is still a small slice of assets, and the company may be relying more on borrowing to fund operations.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-31.54M $-4.37M $30K $-2.45M $4.62M $-7.49M
Q3-2025 $-1.92M $-19.77M $3.7M $14.47M $-1.66M $-23.38M
Q2-2025 $-160K $-11.79M $4.18M $-4.25M $-11.71M $-16.05M
Q1-2025 $-14.35M $-22.11M $-23.97M $49.37M $3.06M $-26.8M
Q4-2024 $-11.71M $6.13M $-1.01M $7.68M $11.82M $854K

What's strong about this company's cash flow?

Cash burn is much lower than last quarter, and most of the reported loss is non-cash. The company is no longer relying on new debt and even paid some back.

What are the cash flow concerns?

Operations are still losing real cash, and the cash balance has dropped a lot over the past two quarters. If losses continue, the current cash cushion won't last.

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
PeopleManagement
PeopleManagement
$140.00M $130.00M $130.00M $140.00M
PeopleReady
PeopleReady
$190.00M $210.00M $250.00M $230.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at TrueBlue, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a diversified set of staffing and workforce solutions brands, well‑developed digital platforms that improve client and worker experiences, and a long operating history with large enterprises across multiple sectors. The company has shown in the recent past that it can generate healthy margins and strong cash flow when conditions are favorable. Its push into higher‑value areas like healthcare staffing and its reputation for ethical practices also support customer trust and open doors to more resilient end markets.

! Risks

Major risks stem from the combination of declining revenue, sustained operating losses, and negative cash flow. The shrinking asset and equity base, rising leverage, and weaker liquidity mean the balance sheet is less able to absorb further shocks. Competitive intensity from both traditional staffing firms and digital platforms could keep pressure on pricing and volumes. Execution risk around cost restructuring, technology monetization, and integration of new verticals such as healthcare is high, especially when financial flexibility is constrained.

Outlook

The forward picture is mixed and uncertain. On one hand, TrueBlue has meaningful assets in technology, brand diversity, and sector reach that could support a recovery if economic conditions improve and its strategic initiatives in sales expansion, partnerships, and healthcare staffing gain traction. On the other hand, the current financial trajectory—shrinking revenue, thin or negative margins, weaker cash generation, and higher debt—indicates that the company is in a challenging transition. The medium‑term outlook largely depends on its ability to stabilize volumes, rebuild profitability, and convert its innovation and diversification efforts into durable, cash‑generating growth while carefully managing financial risk.